期刊文献+

阿托伐他汀和卡托普利对高压培养下大鼠系膜细胞外基质的影响 被引量:1

Effects of atorvastatin and captopril on the extracellular matrix of rat mesangial cells cultured under high hydrostaticpressure
下载PDF
导出
摘要 目的观察阿托伐他汀和卡托普利干预对连续周期性波动的高静水压下大鼠肾小球系膜细胞(RMC)细胞外基质(ECM)的影响。方法RMC分别在生理压力(40mmHg,PP)、中压(60mmHg,MP)、高压(80mmHg,HP)环境下,不同药物(阿托伐他汀、卡托普利)中培养1、3、5、7d。采用Western Blotting法测定细胞裂解液中胶原Ⅰ和Ⅳ、纤维连结生长因子(FN)的含量。结果与PP组第1天相比,PP组第3、5、7天胶原Ⅰ/Ⅳ、FN浓度无明显变化;MP和HP组从第1天开始可见胶原Ⅰ/Ⅳ、FN水平呈时间依赖性升高,7d达到最高。阿托伐他汀和卡托普利均能抑制MP、HP组胶原Ⅰ/Ⅳ和FN水平上升,胶原Ⅰ在1d时,阿托伐他汀吸光度(A)值为1.06±0.12,1.16±0.14vs0.78±0.05;卡托普利A值为0.96±0.09,1.02±0.13vs0.71±0.06(P<0.05)。二者合用可使胶原Ⅰ/Ⅳ和FN水平进一步下降。结论周期性波动的高静水压可使ECM积聚。阿托伐他汀和卡托普利能减轻高静水压引起的ECM积聚。二者合用存在协同作用。 Objective To investigate the effects of atorvastatin and captopril on the extracelluar matrix(ECM) of rat mesangial cells (RMC) under continual high hydrostatic pressure. Methods RMCs were exposed to physiological pressure (40 mm Hg, PP), moderate pressure (60 mm Hg, MP), high pressure (80 mm Hg, HP ) 1,3,5,7 days respectively. Each pressure condition was satisfied in five groups: control,captopril (10μLmol/L).atorvastatin (10 μmol/L),captopril+atorvastatin(10μmol/L-10μmol/L) and dimethylsulfoxide. The treatment group contentration of FN, coLLagen Ⅰ .Ⅳ were tested with western blotting in the supernatant of lysate. Results Compared with the 1^st day of PP, the level of collagen Ⅰ was elevated significantly from 1^st day on MP and HP, dchieved the highest level at 7^th day. The change of FN, collagen Ⅳ were similar to collagen Ⅰ. Both atorvastatin and eaptopril could partly inhibit the elevation of extracellular matrix (collagen Ⅰ: 1 d, atorvastatin: 1.06±0.12, 1.16±0.14 vs 0.78±0.05;eaptopril:0.96±0.09, 1.02±0.13 vs 0.71±0.06; P〈0.05). Atorvastatin combined with captopril can decrease collagen Ⅰ ,collagen Ⅳ and FIN better. Conclusions The recurrent fluctuant static pressure above physiological pressure can induce the accumulation of ECM. Both atorvastatin and captopril can inhibit the deleterious effects of high hydrostatic pressure. Captopril and atorvastatin are synergistic.
出处 《北京医学》 CAS 2007年第3期163-166,共4页 Beijing Medical Journal
基金 国家自然科学基金资助项目(30260037)
关键词 系膜细胞 细胞外基质 阿托伐他汀 卡托普利 高静水压 Mesangial cell Extracelluar matrix Atorvastatin Captopril High hydrostatic pressure
  • 相关文献

参考文献11

二级参考文献33

  • 1王昕,刘超,刘翠萍,杨涛,武晓泓,魏群利.阿妥伐他汀对高糖培养肾小球系膜细胞增殖及细胞周期的影响[J].南京医科大学学报(自然科学版),2004,24(6):572-574. 被引量:3
  • 2耿纪录,陆菊明,潘长玉,汪保安,刘艳芳,巴建明.胰岛素和卡托普利对糖尿病大鼠肾小球系膜细胞的影响[J].中华医学杂志,1996,76(1):41-44. 被引量:5
  • 3刘艳芳,潘长玉,陆菊明,田慧.培哚普利对糖尿病大鼠肾内肾素血管紧张素系统的影响[J].中华医学杂志,1996,76(7):512-515. 被引量:9
  • 4Tonolo G, Melis MG, Formato M, et al. Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients[J]. Eur J Clin Invest,2000,30:980-987.
  • 5Malhotra R, Sadoshima J, Brosius FC, et al. Mechanical stretch and angiotensin Ⅱ differentially upregulate the Renin-Angiotensin system in cardiac myocytes in vitro [J]. Circulation Research, 1999,85: 137-146.
  • 6Kim SI, Kim HJ, Han DC, et al. Effect of lovastatin on small GTP binding proteins and on TGF-β1 and fibronectin expression[J]. Kidney int, 2000, 58:S88-92.
  • 7Ding GH, Krishna R, Aditi AK, et al. Angiotensin Ⅱ induces apoptosis in rat glomerular epithelial cells[J]. Am J Physiol Renal Physiol,2002,283,F173-F180.
  • 8Cheng JF, Grande JP. Transforming growth factor-β signal transduction and progressive renal disease[J]. Exp Biol Med,2002,227:943-956.
  • 9Sharma K, Eltayeb BO, McGowan TA, et al. Captopril-induced reduction of serum levels of transforming growth factor-β1 correlates with long-term renoprotection in insulin-dependent diabetic patients[J]. Am J Kidney Dis, 1999,34: 818-823.
  • 10[4]Kim SL, Han DC, Lee HB, et al. Lovastatin inhibts transforming growth factor-β1 expression in diabetic rat glomeruli and cultured rat mesangial cells [J]. J Am Soc Nephrol, 2000, 23 (11): 80-87.

共引文献162

同被引文献11

  • 1沈云峰,程晓曙,徐劲松,杨人强,董一飞,苏海,吴清华,吴延庆.阿托伐他汀和卡托普利对系膜细胞增殖及转化生长因子β_1的影响[J].高血压杂志,2006,14(1):46-51. 被引量:4
  • 2徐金兰,刘晓云,王景俊.他汀类药物的临床应用[J].中国医药,2006,1(1):63-64. 被引量:8
  • 3Mogensen CE, Schmitz A, Christensen CK. Comparative renal pathophysiology relevant to IDDM and NIDDM patients [ J]. Diabetes Metabol Rev, 1998,4 (5) :453-483.
  • 4Levin SR, Comstock JP, Coburn JW, et al. Effect of intensive glycemic control on microalbumiuria in type 2 diabetes [ J ]. Diabetes Care ,2000,23 ( 10 ) : 1478-1485.
  • 5UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes : UKPDS38 [ J ]. BMJ, 1998,317 (9) :703-713.
  • 6West of Scotland Coronary Prevention Group. West of Scotland Coronary Prevention Study:identification of high-risk groups and comparison with other cardiovascular intervention trials [ J ]. Lancet, 1996, 348 ( 11 ) : 1339-1342.
  • 7The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels [ J ].N Engl J Med, 1998,339 ( 11 ) : 1349-1357.
  • 8Scandinavian Simvastatin Survival Study Group. Rando raised trial of cholesterol lowering in 4444 patients with coronary heart disease : the Scandinavian Simvastatin Survival Study ( 4S ) [J].Lancet, 1994, 344 ( 11 ) : 1383-1389.
  • 9沈云峰,程晓曙,徐劲松,杨人强,董一飞,苏海,吴清华,吴延庆.阿托伐他汀和卡托普利对高压培养下大鼠系膜细胞产生PAI-1和tPA的影响[J].临床心血管病杂志,2007,23(8):612-615. 被引量:1
  • 10姚建,陈名道.糖尿病肾病及其早期防治[J].中华内分泌代谢杂志,2002,18(4):330-331. 被引量:260

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部